JAX donors contribute $100,000 to new COVID-19 models

JAX is fulfilling an urgent need for accurate animal models to test vaccines, neutralizing antibodies and other therapeutics against the SARS-CoV-2 virus to protect the global community against future COVID-19 pandemics. In humans, the virus enters cells by binding to ACE2, a cell surface protein that is slightly different in mice, which as a species, are not naturally susceptible to the disease.  JAX is currently distributing a mouse model called K18-hACE2, donated by its creators Stanley Perlman and Paul McCray, that overcomes this obstacle through the introduction of human ACE2 genes. The resulting transgenic mouse is highly susceptible to SARS-CoV-2 infection. The dissemination of the K18-haACE2 model by JAX is a huge step forward for pre-clinical testing of vaccines and antiviral drugs.

 Next-generation models for COVID-19 research

Thanks in part to recent gifts totaling $100,000 from supporters, JAX scientists will now develop innovative, more accurate mouse models for COVID-19 research that authentically mimic human responses to the viral life cycle. The new models will enable exploration of common and often lethal complications in COVID-19 patients with hypertension, diabetes or cardiovascular conditions. Read more

Related Posts

Bangor will be abuzz with Maine science at annual festival

The Maine Science Festival’s headlining event will be a major collaboration with a local arts organization for the second year in...

23 March 2023

Report: National Institutes of Health added $264M to Maine economy in 2022

The National Institutes of Health supported 1,950 jobs and $264 million in economic activity in Maine during 2022 through $112.7 million in grants and...

22 March 2023

Northern Light completes deal to outsource diagnostics to Quest

Quest Diagnostics (NYSE: DGX), a Secaucus, N.J.-based diagnostic information services provider with a national footprint, said Monday that it has completed the acquisition...

21 March 2023